Producer Prices in Canada decreased to 130.20 points in April from 131.30 points in March of 2025. This dataset provides the latest reported value for - Canada Producer Prices - plus previous releases, historical high and low, short-term forecast and long-term prediction, economic calendar, survey consensus and news.

Key information about Canada Producer Price Index Growth

• Canada Producer Price Index (PPI) grew 4.9 % YoY in Feb 2025, compared with a growth of 5.6 % YoY in the previous month.
• Canada Producer Price Index data is updated monthly, available from Jan 1957 to Feb 2025, with an average change of 2.2 % YoY.
• The data reached an all-time high of 21.5 % YoY in Nov 1974 and a record low of -7.1 % YoY in Jul 2009.

Graph and download economic data for Producer Prices Index: Economic Activities: Manufacturing: Total for Canada (CANPIEAMP01GYM) from Jan 1957 to Dec 2022 about Canada, manufacturing, PPI, price index, indexes, and price.

Canada CA: Producer Price Index: Aggregate Industry Selling Price data was reported at 117.924 2010=100 in 2018. This records an increase from the previous number of 113.549 2010=100 for 2017. Canada CA: Producer Price Index: Aggregate Industry Selling Price data is updated yearly, averaging 66.667 2010=100 from Dec 1956 (Median) to 2018, with 63 observations. The data reached an all-time high of 117.924 2010=100 in 2018 and a record low of 15.816 2010=100 in 1956. Canada CA: Producer Price Index: Aggregate Industry Selling Price data remains active status in CEIC and is reported by International Monetary Fund. The data is categorized under Global Database’s Canada – Table CA.IMF.IFS: Consumer and Producer Price Index: Annual.

Graph and download economic data for Producer Prices Index: Economic Activities: Manufacture of Food Products: Total for Canada (CANPIEAFD01GYM) from Jan 1960 to Dec 2022 about Canada, production, manufacturing, PPI, price index, indexes, and price.

This infographic demonstrates how producer price indexes for goods and services are calculated and why they are important for the Canadian economy. This infographic highlights the Industrial Product Price Index (IPPI), the New Housing Price Index (NHPI), the Retail Services Price Index (RSPI) and the Accounting Services Price Index (ASPI).

Canada CA: Producer Price Index: % Change data was reported at 2.354 % in Apr 2018. This records a decrease from the previous number of 2.366 % for Mar 2018. Canada CA: Producer Price Index: % Change data is updated monthly, averaging 2.341 % from Jan 1957 (Median) to Apr 2018, with 736 observations. The data reached an all-time high of 21.408 % in Nov 1974 and a record low of -7.204 % in Jul 2009. Canada CA: Producer Price Index: % Change data remains active status in CEIC and is reported by International Monetary Fund. The data is categorized under Global Database’s Canada – Table CA.IMF.IFS: Consumer and Producer Price Index.

Canada CA: Producer Price Index: % Change data was reported at 3.133 % in 2017. This records an increase from the previous number of -0.204 % for 2016. Canada CA: Producer Price Index: % Change data is updated yearly, averaging 2.037 % from Dec 1957 (Median) to 2017, with 61 observations. The data reached an all-time high of 18.989 % in 1974 and a record low of -3.501 % in 2009. Canada CA: Producer Price Index: % Change data remains active status in CEIC and is reported by International Monetary Fund. The data is categorized under Global Database’s Canada – Table CA.IMF.IFS: Consumer and Producer Price Index: Annual.

Machinery and equipment price index (MEPI) by Supply Use Product Classification (SUPC). Quarterly Data are available from the first quarter of 1997. The table presents data for the most recent reference period and the last four periods. The base period for the index is (2016=100).

Producer price index, goods - Industrial product price indexes

Graph and download economic data for Producer Prices Index: Stage of Processing: Total Finished Goods for Canada (DISCONTINUED) (PISPFG01CAQ661N) from Q1 1981 to Q3 2013 about finished, Canada, goods, PPI, price index, indexes, and price.

Ppi Canada Company Export Import Records. Follow the Eximpedia platform for HS code, importer-exporter records, and customs shipment details.

A inflação de preços ao produtor (IPP) mensal no Canadá diminuiu para -0,80 por cento em abril, em comparação com 0,50 por cento em março de 2025. Esta página inclui um gráfico com dados históricos para o Índice de Preços ao Produtor do Canadá, variação mensal.

Subscribers can find out export and import data of 23 countries by HS code or product’s name. This demo is helpful for market analysis.

Los precios al productor en Canadá aumentaron un 4.70 por ciento en marzo de 2025 en comparación con el mismo mes del año anterior. Esta página ofrece el valor más reciente reportado para - Cambio en los Precios de los Productores de Canadá - además de versiones anteriores, máximos y mínimos históricos, pronóstico a corto plazo y predicción a largo plazo, calendario económico, consenso de encuestas y noticias.

Graph and download economic data for Producer Prices Index: Economic Activities: Manufacturing: Domestic for Canada (CANPPDMAINMEI) from 1960 to 2022 about Canada, domestic, manufacturing, PPI, price index, indexes, and price.

Graph and download economic data for Producer Prices Index: Economic Activities: Total Energy for Canada (DISCONTINUED) (PIEAEN01CAA661N) from 2002 to 2008 about Canada, energy, PPI, price index, indexes, and price.

Snapshot img

Proton Pump Inhibitors Market Size 2025-2029

The proton pump inhibitors market size is forecast to increase by USD 819.5 million at a CAGR of 4.7% between 2024 and 2029.

Proton Pump Inhibitors (PPIs) are a class of drugs widely used for the treatment of gastroesophageal reflux disease (GERD), peptic ulcers, and other gastric conditions. The PPIs market is witnessing significant trends and challenges, primarily driven by advancements in genomics and artificial intelligence. The integration of genomics in drug development is leading to the creation of personalized medicine, enabling better treatment outcomes and reduced side effects. Moreover, the adoption of new drug delivery systems, such as transdermal patches and pumps, is enhancing patient compliance and improving therapeutic efficacy. The increasing use of analytics and big data in healthcare is facilitating better diagnosis and treatment of gastrointestinal diseases.
However, challenges persist, including the growing number of lawsuits against PPIs due to their association with adverse health effects, such as kidney damage and heart attacks. Additionally, the tobacco industry's marketing tactics continue to pose a significant threat to public health, increasing the prevalence of gastrointestinal diseases and driving demand for PPIs. In conclusion, the PPIs market is experiencing significant growth, driven by advancements in genomics, artificial intelligence, and digital health technologies. However, challenges, including the increasing number of lawsuits and the tobacco industry's marketing tactics, are hindering market growth.

What will be the Size of the Proton Pump Inhibitors Market During the Forecast Period?

Request Free Sample

The market encompasses a range of acid-suppressing medications used to treat various acid-related disorders, including gastroesophageal reflux disease (GERD), peptic ulcers, and other gastric conditions. These medications work by inhibiting the gastric proton pump, thereby reducing stomach acid production. 
The market for PPIs has experienced significant growth due to the increasing prevalence of acid-related disorders, driven by poor dietary choices, sedentary work cultures, stress, and an aging population. Drug formulations include both prescription and over-the-counter (OTC) options, with popular PPIs including lansoprazole, esomeprazole, rabeprazole, dexlansoprazole, and pantoprazole. The market is expected to continue growing as healthcare investments prioritize pharmaceutical solutions for gastrointestinal health.
Digital health technologies, including telemedicine and digital platforms, are gaining popularity, providing patients with easy access to healthcare services and remote monitoring capabilities. Injectable and oral formulations are available to cater to diverse patient needs. Overall, the market for PPIs reflects a robust demand for effective treatments for acid-related disorders, driven by a growing awareness of the impact of unhealthy lifestyles on gastrointestinal health.

How is this Proton Pump Inhibitors Industry segmented and which is the largest segment?

The PPI industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product

  OTC PPIs
  Prescription PPIs


Route Of Administration

  Oral
  Injectable


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK
    France


  Asia

    China
    India
    Japan


  Rest of World (ROW)

By Product Insights

The otc ppis segment is estimated to witness significant growth during the forecast period. Proton Pump Inhibitors (PPIs) are a class of acid-suppressing medications used to treat various acid-related disorders, including gastroesophageal reflux disease (GERD), peptic ulcers, and other digestive issues. These medications inhibit the gastric proton pump, reducing acid secretion in the stomach. PPIs are available in various formulations, including capsules and injectables, and are used for both prescription and over-the-counter (OTC) sales. The market for PPIs is driven by an aging population, poor dietary choices, sedentary lifestyles, stress, and irregular eating patterns. Key brands include Omeprazole, Lansoprazole, Esomeprazole, Rabeprazole, and Pantoprazole. Personalized medicine approaches and safety concerns are influencing the development of new formulations and therapies.

The market is also influenced by healthcare investment, molecular biology, genomics, artificial intelligence, and big data. The middle class and disposable incomes contribute significantly to healthcare expenditure, making PPIs an attractive investment for pharmaceutical solutions. OTC PPIs, such as Prevacid, Nexium, Prilosec, and Zegerid, are widely used for the treatment of frequen

Graph and download economic data for Producer Prices Index: Stage of Processing: Total Primary Products for Canada (PISPPR01CAM661N) from Jan 1981 to Sep 2020 about materials, supplies, primary, Canada, PPI, price index, indexes, and price.

Health Canada reviewed the potential risk of a type of skin reaction known as subacute cutaneous lupus erythematosus(SCLE) with the use of PPIs after a published article that found these drugs may contribute to the reaction.